Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of bone metastases in urologic malignancies.
Froehner M, Hölscher T, Hakenberg OW, Wirth MP. Froehner M, et al. Among authors: holscher t. Urol Int. 2014;93(3):249-56. doi: 10.1159/000365788. Epub 2014 Aug 7. Urol Int. 2014. PMID: 25115989 Review.
Reply to Piet R. Dirix, Carole Mercier, and Luc Y. Dirix's Letter to the Editor re: Fabian Lohaus, Klaus Zöphel, Steffen Löck, et al. Can Local Ablative Radiotherapy Revert Castration-resistant Prostate Cancer to an Earlier Stage of Disease? Eur Urol 2019;75:548-51.
Hölscher T, Lohaus F, Wirth M, Troost EGC. Hölscher T, et al. Eur Urol. 2019 Oct;76(4):e103-e104. doi: 10.1016/j.eururo.2019.06.021. Epub 2019 Jun 27. Eur Urol. 2019. PMID: 31256943 No abstract available.
68Ga-RM2 PET in PSMA- positive and -negative prostate cancer patients.
Hoberück S, Michler E, Wunderlich G, Löck S, Hölscher T, Froehner M, Braune A, Ivan P, Seppelt D, Zöphel K, Kotzerke J. Hoberück S, et al. Among authors: holscher t. Nuklearmedizin. 2019 Sep;58(5):352-362. doi: 10.1055/a-0990-8898. Epub 2019 Aug 23. Nuklearmedizin. 2019. PMID: 31443113 English.
Toxicity and Efficacy of Local Ablative, Image-guided Radiotherapy in Gallium-68 Prostate-specific Membrane Antigen Targeted Positron Emission Tomography-staged, Castration-sensitive Oligometastatic Prostate Cancer: The OLI-P Phase 2 Clinical Trial.
Hölscher T, Baumann M, Kotzerke J, Zöphel K, Paulsen F, Müller AC, Zips D, Koi L, Thomas C, Löck S, Krause M, Wirth M, Lohaus F. Hölscher T, et al. Eur Urol Oncol. 2022 Feb;5(1):44-51. doi: 10.1016/j.euo.2021.10.002. Epub 2021 Nov 14. Eur Urol Oncol. 2022. PMID: 34785189 Free article. Clinical Trial.
Local Control after Locally Ablative, Image-Guided Radiotherapy of Oligometastases Identified by Gallium-68-PSMA-Positron Emission Tomography in Castration-Sensitive Prostate Cancer Patients (OLI-P).
Hölscher T, Baumann M, Kotzerke J, Zöphel K, Paulsen F, Müller AC, Zips D, Thomas C, Wirth M, Troost EGC, Krause M, Löck S, Lohaus F. Hölscher T, et al. Cancers (Basel). 2022 Apr 21;14(9):2073. doi: 10.3390/cancers14092073. Cancers (Basel). 2022. PMID: 35565207 Free PMC article.
127 results